1. Home
  2. SJW vs WVE Comparison

SJW vs WVE Comparison

Compare SJW & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SJW
  • WVE
  • Stock Information
  • Founded
  • SJW 1866
  • WVE 2012
  • Country
  • SJW United States
  • WVE Singapore
  • Employees
  • SJW N/A
  • WVE N/A
  • Industry
  • SJW Water Supply
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • SJW Utilities
  • WVE Health Care
  • Exchange
  • SJW Nasdaq
  • WVE Nasdaq
  • Market Cap
  • SJW 1.8B
  • WVE 1.7B
  • IPO Year
  • SJW N/A
  • WVE 2015
  • Fundamental
  • Price
  • SJW $54.17
  • WVE $7.74
  • Analyst Decision
  • SJW Buy
  • WVE Strong Buy
  • Analyst Count
  • SJW 2
  • WVE 11
  • Target Price
  • SJW $56.00
  • WVE $22.00
  • AVG Volume (30 Days)
  • SJW 232.2K
  • WVE 1.3M
  • Earning Date
  • SJW 04-24-2025
  • WVE 03-04-2025
  • Dividend Yield
  • SJW 3.10%
  • WVE N/A
  • EPS Growth
  • SJW 7.09
  • WVE N/A
  • EPS
  • SJW 2.87
  • WVE N/A
  • Revenue
  • SJW $748,439,000.00
  • WVE $108,302,000.00
  • Revenue This Year
  • SJW $3.60
  • WVE N/A
  • Revenue Next Year
  • SJW $1.50
  • WVE $33.28
  • P/E Ratio
  • SJW $19.06
  • WVE N/A
  • Revenue Growth
  • SJW 11.65
  • WVE N/A
  • 52 Week Low
  • SJW $44.91
  • WVE $4.25
  • 52 Week High
  • SJW $62.18
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • SJW 56.89
  • WVE 31.52
  • Support Level
  • SJW $50.73
  • WVE $9.43
  • Resistance Level
  • SJW $55.82
  • WVE $10.91
  • Average True Range (ATR)
  • SJW 1.34
  • WVE 0.63
  • MACD
  • SJW 0.06
  • WVE -0.18
  • Stochastic Oscillator
  • SJW 67.58
  • WVE 3.21

About SJW SJW Group (DE)

SJW Group is a U.S. water utility services holding company that provides, stores, purifies and distributes water. The company predominantly operates in various Californian municipalities and also has operations in other states. Its operating segments include Water Utility Services and Real Estate Services. The majority of the company's revenue is derived from its water utility services segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: